1 / 10

Pernia -Andrade et al. (2009) Science 325:760-764.

Spinal Endocannabinoids and CB 1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization. Pernia -Andrade et al. (2009) Science 325:760-764. What are cannabinoids?.

katina
Télécharger la présentation

Pernia -Andrade et al. (2009) Science 325:760-764.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Spinal Endocannabinoids and CB1Receptors Mediate C-Fiber–InducedHeterosynaptic Pain Sensitization Pernia-Andrade et al. (2009) Science 325:760-764.

  2. What are cannabinoids? • Lipid neurotransmitters that are synthesized on demand (activity-dependent) and require an active transport molecule (?) to move across the synaptic cleft. • Endocannabinoids = endogenous cannabinoids • 2-arachydonoyl glycerol (2AG) and anandamide (AEA) are the most prevalent endocannabinoids • Receptors • CB1 and CB2, both G protein-coupled receptors • TRPV1 (transient receptor potential vanilloid 1), an ionotropic receptor that also responds to heat and H+ • GPR55, a third G protein-coupled receptor (still debated)

  3. There is considerable interest in developing cannabiniod-based analgesics • This is largely motivated by problems with many of the opioid-based analgesics. • Potential for abuse (higher rates for death by overdose than some illegal drugs) • Depress respiration • Can initiate rebound hyperalgesia • Current cannabinoid-based treatments use analogs of endogenous cannabinoids transmitters (agonists) • e.g. marinol (synthetic THC) and cannabidiol • A better approach may be drugs that increase endocannabinoid levels (increase synthesis or transport, decrease metabolism).

  4. Endocannabinoid signaling Guindon & Hohmann, 2009

  5. Fig. 1. Synaptic effects of CB1 receptor activation in dorsal horn neuronal Pernia-Andrade et al. 2009

  6. Paired-pulse Facilitation Presynaptic Action Potentials Postsynaptic EPSPs Red arrows indicate timing of presynaptic action potentials 1 sec

  7. Fig. 2. Inhibition of glycinergicand GABAergic synaptic transmission via presynaptic CB1 receptors. Paired-pulse Coefficient of variation

  8. Fig. 3. Extracellular single-unit recordings from deep dorsal horn neurons in intact rats.

  9. Fig. 4. Effects of pharmacological and genetic manipulations of the endocannabinoid system on capsaicin-induced mechanical hyperalgesia in mice.

  10. Fig. S8. Schematic representation of a neuronal model circuit of the spinal dorsal horn possibly underlying activity-dependent and endocannabinoid-mediated secondary hyperalgesia.

More Related